Nasdaq drops Largo's embattled GeoPharma
Shares in struggling Largo drugmaker GeoPharma will be delisted from Nasdaq effective Monday.
GeoPharma said Friday that the company's request for continued listing was denied by Nasdaq. It is considering a request for an additional review. The news came after the close of market Friday. Shares closed Friday at less than one cent.
GeoPharma has slashed costs and laid off workers this year in efforts to stave off a severe cash crunch.